Pharmaceuticals
23andMe gets FDA nod to sell genetic tests directly to consumers
07 Apr 2017
For the first time the FDA has allowed a company to sell genetic tests for disease risk directly to consumers, which would tell people if they were at risk of developing conditions like Parkinson’s and Alzheimer’s
Astellas Pharma to buy Belgium’s Ogeda for upto $853 mn
03 Apr 2017
Japanese pharmaceutical company Astellas Pharma Inc yesterday struck a deal to buy Belgium-based privately-owned drug discovery firm Ogeda SA
Johnson & Johnson succeeds in $30-bn tender offer for Actelion
31 Mar 2017
J&J had clinched the deal in December after raising its offer to $280 per share or $30 billion in cash, which included spinning off Actelion's research and development pipeline
